T807 (AV-1451), a novel tau positron emission tomography imaging agent for Alzheimer’s disease, exhibits strong binding to phosphorylation tau positive human brain sections [19]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.